Tumor-induced senescent T cells with suppressor function: A potential form of tumor immune evasion

Autores
Montes, Carolina Lucia; Chapoval, Andrei I.; Nelson, Jonas; Orhue, Vbenosa; Zhang, Xiaoyu; Schulze, Dan H.; Strome, Scott E.; Gastman, Brian R.
Año de publicación
2008
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Senescent and suppressor T cells are reported to be increased in select patients with cancer and are poor prognostic indicators. Based on the association of these T cells and poor outcomes, we hypothesized that tumors induce senescence in T cells, which negatively effects antitumor immunity. In this report, we show that human T cells from healthy donors incubated with tumor for only 6 h at a low tumor to T-cell ratio undergo a senescence-like phenotype, characterized by the loss of CD27 and CD28 expression and telomere shortening. Tumor-induced senescence of T cells is induced by soluble factors and triggers increases in expression of senescence-associated molecules such as p53, p21, and p16. Importantly, these T cells are not only phenotypically altered, but also functionally altered as they can suppress the proliferation of responder T cells. This suppression requires cell-to-cell contact and is mediated by senescent CD4+ and CD8+ subpopulations, which are distinct from classically described natural T regulatory cells. Our observations support the novel concept that tumor can induce senescent T cells with suppressor function and may effect both the diagnosis and treatment of cancer. ©2008 American Association for Cancer Research.
Fil: Montes, Carolina Lucia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina
Fil: Chapoval, Andrei I.. University of Maryland; Estados Unidos
Fil: Nelson, Jonas. University of Maryland; Estados Unidos
Fil: Orhue, Vbenosa. University of Maryland; Estados Unidos
Fil: Zhang, Xiaoyu. University of Maryland; Estados Unidos
Fil: Schulze, Dan H.. University of Maryland; Estados Unidos
Fil: Strome, Scott E.. University of Maryland; Estados Unidos
Fil: Gastman, Brian R.. University of Maryland; Estados Unidos
Materia
Senescence
T cell
Tumor
Immunology
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/132360

id CONICETDig_c155015f545c7931acf301f77271dd6e
oai_identifier_str oai:ri.conicet.gov.ar:11336/132360
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Tumor-induced senescent T cells with suppressor function: A potential form of tumor immune evasionMontes, Carolina LuciaChapoval, Andrei I.Nelson, JonasOrhue, VbenosaZhang, XiaoyuSchulze, Dan H.Strome, Scott E.Gastman, Brian R.SenescenceT cellTumorImmunologyhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Senescent and suppressor T cells are reported to be increased in select patients with cancer and are poor prognostic indicators. Based on the association of these T cells and poor outcomes, we hypothesized that tumors induce senescence in T cells, which negatively effects antitumor immunity. In this report, we show that human T cells from healthy donors incubated with tumor for only 6 h at a low tumor to T-cell ratio undergo a senescence-like phenotype, characterized by the loss of CD27 and CD28 expression and telomere shortening. Tumor-induced senescence of T cells is induced by soluble factors and triggers increases in expression of senescence-associated molecules such as p53, p21, and p16. Importantly, these T cells are not only phenotypically altered, but also functionally altered as they can suppress the proliferation of responder T cells. This suppression requires cell-to-cell contact and is mediated by senescent CD4+ and CD8+ subpopulations, which are distinct from classically described natural T regulatory cells. Our observations support the novel concept that tumor can induce senescent T cells with suppressor function and may effect both the diagnosis and treatment of cancer. ©2008 American Association for Cancer Research.Fil: Montes, Carolina Lucia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Chapoval, Andrei I.. University of Maryland; Estados UnidosFil: Nelson, Jonas. University of Maryland; Estados UnidosFil: Orhue, Vbenosa. University of Maryland; Estados UnidosFil: Zhang, Xiaoyu. University of Maryland; Estados UnidosFil: Schulze, Dan H.. University of Maryland; Estados UnidosFil: Strome, Scott E.. University of Maryland; Estados UnidosFil: Gastman, Brian R.. University of Maryland; Estados UnidosAmerican Association for Cancer Research2008-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/132360Montes, Carolina Lucia; Chapoval, Andrei I.; Nelson, Jonas; Orhue, Vbenosa; Zhang, Xiaoyu; et al.; Tumor-induced senescent T cells with suppressor function: A potential form of tumor immune evasion; American Association for Cancer Research; Cancer Research; 68; 3; 2-2008; 870-8790008-54721538-7445CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1158/0008-5472.CAN-07-2282info:eu-repo/semantics/altIdentifier/url/https://cancerres.aacrjournals.org/content/68/3/870info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:53:42Zoai:ri.conicet.gov.ar:11336/132360instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:53:42.655CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Tumor-induced senescent T cells with suppressor function: A potential form of tumor immune evasion
title Tumor-induced senescent T cells with suppressor function: A potential form of tumor immune evasion
spellingShingle Tumor-induced senescent T cells with suppressor function: A potential form of tumor immune evasion
Montes, Carolina Lucia
Senescence
T cell
Tumor
Immunology
title_short Tumor-induced senescent T cells with suppressor function: A potential form of tumor immune evasion
title_full Tumor-induced senescent T cells with suppressor function: A potential form of tumor immune evasion
title_fullStr Tumor-induced senescent T cells with suppressor function: A potential form of tumor immune evasion
title_full_unstemmed Tumor-induced senescent T cells with suppressor function: A potential form of tumor immune evasion
title_sort Tumor-induced senescent T cells with suppressor function: A potential form of tumor immune evasion
dc.creator.none.fl_str_mv Montes, Carolina Lucia
Chapoval, Andrei I.
Nelson, Jonas
Orhue, Vbenosa
Zhang, Xiaoyu
Schulze, Dan H.
Strome, Scott E.
Gastman, Brian R.
author Montes, Carolina Lucia
author_facet Montes, Carolina Lucia
Chapoval, Andrei I.
Nelson, Jonas
Orhue, Vbenosa
Zhang, Xiaoyu
Schulze, Dan H.
Strome, Scott E.
Gastman, Brian R.
author_role author
author2 Chapoval, Andrei I.
Nelson, Jonas
Orhue, Vbenosa
Zhang, Xiaoyu
Schulze, Dan H.
Strome, Scott E.
Gastman, Brian R.
author2_role author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Senescence
T cell
Tumor
Immunology
topic Senescence
T cell
Tumor
Immunology
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Senescent and suppressor T cells are reported to be increased in select patients with cancer and are poor prognostic indicators. Based on the association of these T cells and poor outcomes, we hypothesized that tumors induce senescence in T cells, which negatively effects antitumor immunity. In this report, we show that human T cells from healthy donors incubated with tumor for only 6 h at a low tumor to T-cell ratio undergo a senescence-like phenotype, characterized by the loss of CD27 and CD28 expression and telomere shortening. Tumor-induced senescence of T cells is induced by soluble factors and triggers increases in expression of senescence-associated molecules such as p53, p21, and p16. Importantly, these T cells are not only phenotypically altered, but also functionally altered as they can suppress the proliferation of responder T cells. This suppression requires cell-to-cell contact and is mediated by senescent CD4+ and CD8+ subpopulations, which are distinct from classically described natural T regulatory cells. Our observations support the novel concept that tumor can induce senescent T cells with suppressor function and may effect both the diagnosis and treatment of cancer. ©2008 American Association for Cancer Research.
Fil: Montes, Carolina Lucia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina
Fil: Chapoval, Andrei I.. University of Maryland; Estados Unidos
Fil: Nelson, Jonas. University of Maryland; Estados Unidos
Fil: Orhue, Vbenosa. University of Maryland; Estados Unidos
Fil: Zhang, Xiaoyu. University of Maryland; Estados Unidos
Fil: Schulze, Dan H.. University of Maryland; Estados Unidos
Fil: Strome, Scott E.. University of Maryland; Estados Unidos
Fil: Gastman, Brian R.. University of Maryland; Estados Unidos
description Senescent and suppressor T cells are reported to be increased in select patients with cancer and are poor prognostic indicators. Based on the association of these T cells and poor outcomes, we hypothesized that tumors induce senescence in T cells, which negatively effects antitumor immunity. In this report, we show that human T cells from healthy donors incubated with tumor for only 6 h at a low tumor to T-cell ratio undergo a senescence-like phenotype, characterized by the loss of CD27 and CD28 expression and telomere shortening. Tumor-induced senescence of T cells is induced by soluble factors and triggers increases in expression of senescence-associated molecules such as p53, p21, and p16. Importantly, these T cells are not only phenotypically altered, but also functionally altered as they can suppress the proliferation of responder T cells. This suppression requires cell-to-cell contact and is mediated by senescent CD4+ and CD8+ subpopulations, which are distinct from classically described natural T regulatory cells. Our observations support the novel concept that tumor can induce senescent T cells with suppressor function and may effect both the diagnosis and treatment of cancer. ©2008 American Association for Cancer Research.
publishDate 2008
dc.date.none.fl_str_mv 2008-02
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/132360
Montes, Carolina Lucia; Chapoval, Andrei I.; Nelson, Jonas; Orhue, Vbenosa; Zhang, Xiaoyu; et al.; Tumor-induced senescent T cells with suppressor function: A potential form of tumor immune evasion; American Association for Cancer Research; Cancer Research; 68; 3; 2-2008; 870-879
0008-5472
1538-7445
CONICET Digital
CONICET
url http://hdl.handle.net/11336/132360
identifier_str_mv Montes, Carolina Lucia; Chapoval, Andrei I.; Nelson, Jonas; Orhue, Vbenosa; Zhang, Xiaoyu; et al.; Tumor-induced senescent T cells with suppressor function: A potential form of tumor immune evasion; American Association for Cancer Research; Cancer Research; 68; 3; 2-2008; 870-879
0008-5472
1538-7445
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1158/0008-5472.CAN-07-2282
info:eu-repo/semantics/altIdentifier/url/https://cancerres.aacrjournals.org/content/68/3/870
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv American Association for Cancer Research
publisher.none.fl_str_mv American Association for Cancer Research
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269242428227584
score 13.13397